Danaher earnings were $3.8B for the trailing 12 months ending Mar 28, 2025, with -12.9% growth year over year. The latest DHR earnings report on Mar 28, 2025 announced Q1 2025 earnings of $954.0M, down 12.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DHR reported annual earnings of $3.9B, with -17.8% growth.
DHR past earnings growth
How has DHR's earnings growth performed historically?
On DHR's earnings call on Invalid Date, Danaher (NYSE: DHR) reported Q1 2025 earnings per share (EPS) of $1.33, up 9.52% year over year. Total DHR earnings for the quarter were $954.00 million. In the same quarter last year, Danaher's earnings per share (EPS) was $1.47.
As of the last Danaher earnings report, Danaher is currently profitable. Danaher's net profit (also called net income) for the twelve months ending Mar 28, 2025 was $3.77 billion, a 14.47% decrease year over year.
What was DHR's earnings growth in the past year?
As of Danaher's earnings date in Invalid Date, Danaher's earnings has grown -12.92% year over year. This is 12.58 percentage points lower than the US Diagnostics & Research industry earnings growth rate of -0.34%. DHR earnings in the past year totalled $3.77 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.